12 December 2024 -- Cambridge, UK -- electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10 Jan in Las Vegas, USA.
12 December 2024
19 November 2024 -- Missouri, US -- TaBlitz is excited to introduce its newest platform partner, BIOGRUND, a globally recognized leader in excipient technolog. This exclusive partnership is set to bring significant value to TaBlitz’s ecosystem, enhancing our capabilities in tablet development.
19 November 2024
IPT speaks to Michael Ruch at TaBlitz about the use of AI in tablet design, why it’s effective and how it will develop in the future
22 September 2024
Pharma laboratories should be looking to innovative digital techniques such as data, AI and the cloud to aid drug discovery and research
22 September 2024
A variety of factors like powder flow, material characteristics, compression pressure, turret speed, etc can affect tablet quality and production run time. Any resulting tablet defects can exacerbate production costs or even result in no product at all! Therefore, it’s necessary to characterise the tablet compression process to achieve robust tablets.
2 April 2024
Natoli engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Specialising in tablet compression and encapsulation technology, innovative machines, tooling and solutions that enhance tablet and encapsulation manufacturing processes, Natoli has advanced manufacturing technologies and practices worldwide
24 September 2023
5 December 2024 -- Hamburg, Germany -- Bio-aerosols aren’t welcome in any laboratory. They can consist of bacteria, cell fragments, fungal spores or viruses, as well as byproducts of microbial metabolism. Aerosols are easily generated in various concentrations during simple routine tasks in the laboratory, such as centrifugation, pipetting or shaking.
Product Profile, 5 December 2024
The 1550UA series is a new addition to the existing line of high-quality and affordable high-volume Pulsed Laser Diodes (PLDs) from LASER COMPONENTS Canada. This is in addition to the 905UA series but now at a higher wavelength.
Product Profile, 22 November 2024
LASER COMPONENTS offers a comprehensive range of sources and detectors for medical applications, from advanced imaging to laser surgery. Light plays an extremely important role in all aspects of medicine. Looking beyond the visible spectrum, infrared can also play an important role, measuring the things we cannot see with the human eye.
Product Profile, 17 October 2024
LASER COMPONENTS is excited to provide updated information for our precision multi-wavelength VCSELs. Brightlaser offer extremely compact VCSEL modules with exceptional performance.
Product Profile, 24 September 2024
As photonic applications expand into new fields and markets, we must address the challenges of operating high sensitivity optical detectors in potentially harmful environments. This can include extreme temperatures, shock forces, vibration, radiation, or even the depths of outer space.
Product Profile, 4 September 2024
17 December 2024 -- Paris, France -- Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.
Press Releases, 17 December 202412 December 2024 -- Cambridge, UK -- electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10 Jan in Las Vegas, USA.
Press Releases, 12 December 2024
11 December 2024 -- Tramore, Republic of Ireland -- Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland.
Press Releases, 11 December 2024
11 December 2024 -- Liege, Belgium -- Allegro NV, a biomedical company developing transformative nanotechnology-based devices for degenerative joint disease, today announced that its injectable microparticle gel, hydrocelin, has demonstrated favorable safety in two preclinical studies.
Press Releases, 11 December 2024
10 December 2024 -- Maryland, US -- Sapio Sciences, the science-aware lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025.
Press Releases, 10 December 2024
The world is rapidly changing with numerous and frequent digital transformations. How can these be implemented and utilised effectively to ensure customer-centricity in the pharma sector?
Digital, 6 December 2024
How is generative AI being utilised in drug discovery to improve processes and secure higher-quality drugs?
Digital, 6 December 2024
The use of artificial intelligence is becoming increasingly common in life sciences R&D. In what areas can it be utilised in the most helpful manner?
Digital, 6 December 2024
Cloud-based tools like process analytical technology can be used to improve pharma manufacturing processes, speeding up quality assurance and time-to-market in a cost-effective manner
Digital, 6 December 2024IPT speaks to Michael Ruch at TaBlitz about the use of AI in tablet design, why it’s effective and how it will develop in the future
Digital, 22 September 2024
Discover how natoli engineering empowers the pharmaceutical industry with innovative equipment, expert training, and unparalleled customer support and expertise. We are the global leader in tablet compression tooling. Our commitment to the tablet compression industry is demonstrated through the development of groundbreaking solutions and progressive, continual improvements in our manufacturing processes. Partner with us – we are better together!
What are some leadership and human resource strategies critical to success in the pharma cdmo sector, including best practices, emerging trends and challenges in managing talent within a highly competitive and evolving industry?
Batch manufacturing has been the standard in the pharma industry, however continuous manufacturing is now proving to be the better choice for efficiency, as well as waste and cost reduction. How can new technologies improve this method further?
In the fast-paced world of pharmaceutical manufacturing, efficiency and precision are non-negotiable. For manufacturers dealing with difficult-to-encapsulate powders and formulations, the Natoli NCF-45 Capsule Filling Machine emerges as a game changer. With the potential to pay for itself in the powder you’ll save, the NCF-45 isn’t just a machine, it’s an investment in better yields and greater profits. Better yields = better profits
There are usually two parameters important to pharmaceutical manufacturers: time and money. Is everything still on schedule? And are they still on budget? They need non-stop insight
Focusing on regulation within pharmaceutical manufacturing can help re-centre a company’s priorities, while ensuring compliance. This can be aided by the use of advanced monitoring techniques
Following good manufacturing practices (GMP) is crucial for stability testing. The analytical data generated from stability studies is a pivotal part of a regulatory dossier submission to substantiate the shelf life claimed for the drug product or drug substance and further support that shelf-life post-approval. All aspects of the stability study must be executed to the highest level of quality to ensure...
Protein-based immunotherapies, such as monoclonal antibodies and adoptive cell transfer therapies, are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success
Medical devices should be designed with an awareness of the challenges of a specific disease as well as an awareness of equality, and the uk government has recently produced a new initiative around this, but how will this impact medical device production going forward?
Protein synthesis is the process by which cells build proteins, fundamental molecules necessary for virtually all cellular functions, but how can this be used within the discovery and manufacturing of new drugs and how can it be automated?
This article explores the significant opportunities within the biologics contract development and manufacturing organisation (CDMO) industry to optimize client satisfaction by meeting the critical demands of discerning clients. Six key facets are identified as pivotal to success, while underscoring the fundamental role of a client-centric approach and the importance of building and nurturing strong client relationships.
Robots are revolutionising manufacturing, but manual programming hampers their potential. Robot offline programming offers a digital solution, reducing human work hours by up to 80% and ensuring swift task readiness
In the post-covid-19 era, healthcare grapples with staff shortages and treatment delays, emphasising the need for early diagnosis. While regulatory changes pose challenges, eu extensions provide relief
Proteins govern crucial biological processes, making protein-protein interactions vital for understanding and treating diseases, peptide-based mimics offer tailored therapeutic approaches, yet optimising their efficacy poses challenges
After assessing the various routes of drug administration, oral delivery stands out as the safest and, as a result, the most universally accepted among patients. Single-unit dosage forms, including tablets followed by capsules, have been identified as the preferred designs for immediate or modified release formulations
Drug administration by inhalation is an established technique for treating respiratory and systemic diseases. Effective drug delivery to the lungs requires the aerosolisation and dispersion of a formulation into particles or droplets in the inhalable size range, typically an aerodynamic diameter below 5 µm. In many cases, particle engineering is used to optimise a formulation for efficacy
Ensuring a manufacturing environment stays clear of bacteria and fungi is of utmost importance, especially when it comes to pharmaceuticals. How can this highly specialised monitoring be achieved in a fast, cost-effective manner?
A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
LabVantage Solutions’ Pharmaceutical LIMS is Engine for Digital Transformations
Healthcare and scientific facilities are critical for the health of the global population. During the COVID-19 pandemic, scientific facilities helped to deliver life-saving vaccines, re-emphasising their importance in achieving other scientific milestones in the coming decades
The digitalisation of pharmaceutical manufacturing has come a long way. However, there are still many ways companies can improve systems to grow even further
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field
IPT speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care
IPT speaks to Mikael Hagstroem, CEO of LabVantage Solutions, about the ongoing potential for laboratories of adopting AI and machine learning (ML)
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
Cell line development is integral to research and biotherapeutic production, and so ensuring this process is as robust as possible through next-generation technology is in the industry’s best interests
Discovery and Development, 6 December 2024
How is current spatial biology being utilised in drug discovery and development for complex disease treatments, and how can it be improved?
Discovery and Development, 6 December 2024
Considering the importance and cost associated with oligonucleotide-based therapeutics, how can innovative computing imaging techniques be used to aid in the process, while also creating an audit trail and increasing the data derived from these experiments?
Discovery and Development, 22 September 2024
Since the completion of the human genome project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience
Discovery and Development, 7 July 2024
Synthetic biology has been a cornerstone in recent health advancements, including drug discovery, development and manufacturing, however there are challenges facing this market
Discovery and Development, 7 July 2024
Society recognises outstanding achievements in microscopy, imaging and flow cytometry
Analytics, 22 September 2024
Thermo fisher scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production
Analytics, 18 March 2024
Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years
Analytics, 18 March 2024
IPT caught up with Peter O’Toole, president of the Royal Microscopical Society, to hear how his first few months as president have gone, his plans for the Society and how the field of microscopy might develop over the next few years
Analytics, 20 December 2023
IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future
Analytics, 20 December 2023
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
Analytics, 24 September 2023
The AAPS National Biotechnology Conference (NBC) uncovers the latest science and trends that impact today’s research and pharmaceutical markets, specifically in the areas of biologics, biotechnology products, and advanced therapies.
Conferences and Events , 2 December 2024
28 November 2024 -- Suzhou, China -- BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around the world. This year's event, held in Suzhou, highlighted cutting-edge advancements in drug licensing, supply chain optimization, product promotion, and funding access within the biotech sector.
Conferences and Events , 28 November 2024
28 November 2024 -- Shanghai, China -- BIOCHINA, Asia’s leading platform for biotechnology and pharmaceutical innovation, proudly announces the appointment of an Expert Committee for the upcoming BIOCHINA 2025 International Convention. Set to take place from March 13-15, 2025, in Suzhou, China, the event will bring together global industry leaders, innovators, and experts for three days of insight, collaboration, and advancement in biotechnology.
Conferences and Events , 28 November 2024
21 November 2024 -- London, UK -- London Lab Live 2025 is set to debut on 14–15 May 2025 at ExCeL London, bringing together professionals from across the lab sector to inspire collaboration and innovation. Representing industries such as chemical and material science, FMCG, food and beverage, agriculture, pharma, biotech, medical, real estate, academia, and beyond, the event promises to be the UK’s most dynamic gathering for the lab community.
Conferences and Events , 21 November 2024
19 November 2024 -- Singapore, Singapore -- South-East Asia will now have its first dedicated Process Technology show with the launch of Process Innovation Asia Pacific – Powered by ACHEMA (PIA). Organised by Constellar, with international partner DECHEMA Ausstellungs-GmbH (DECHEMA Exhibitions), its inaugural edition will be held from 19 to 21 November 2024 at Singapore EXPO.
Conferences and Events , 19 November 2024
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
IPT TV, 9 October 2024
Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.
IPT TV, 8 September 2024
Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.
IPT TV, 4 September 2024
Join the world's leading orphan drug and rare disease Congress! 📅 22-25 October, 2024 📍Fira De Barcelona, Montjuic, Barcelona, Spain
IPT TV, 22 July 2024
Take a look at our trailer for the world's leading vaccine event! The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe since 2000.
IPT TV, 22 July 2024
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
